1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with bn 50726 in 10 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (bn 50726) | Trials (bn 50726) | Recent Studies (post-2010) (bn 50726) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 10 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (20.00) | 18.7374 |
1990's | 8 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braquet, P; Egido, J; Garcia-Hoyo, R; González, E; Herrero-Beaumont, G; Maestre, C; Navarro, FJ; Zarco, P | 1 |
Chakrabarty, S; Flores, NA; Fluck, DS; Sheridan, DJ | 1 |
Bazan, HE; Bazan, NG; Braquet, P; Lin, N | 1 |
Braquet, P; Esanu, A; Hosford, D; Laurent, JP; Martin, C; Pommier, J; Rolland, A | 1 |
Bazan, NG; Braquet, PG; Emoto, SE; Esanu, A; Fitzpatrick, JH; Gilboe, DD; Kintner, D | 1 |
Braquet, P; Esanu, A | 1 |
Braquet, P; Chabrier, PE; Lonchampt, MO; Mencia-Huerta, JM; Pignol, B | 1 |
Ferracin, F; Gurari-Rotman, D; Pletscher, A | 1 |
Braquet, P; Chand, N; Howat, DW; Willoughby, DA | 1 |
Braquet, P; Claude, JR; Dutertre-Catella, H; Martin, C; Massicot, F; Warnet, JM | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bn 50726
Article | Year |
---|---|
From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists.
Topics: Animals; Azepines; Diterpenes; Ginkgolides; Humans; Lactones; Piperidines; Plant Extracts; Platelet Activating Factor; Tetrazoles; Thienopyridines; Triazoles | 1991 |
New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists.
Topics: Animals; Azepines; Platelet Activating Factor; Tetrazoles; Thienopyridines; Triazoles | 1991 |
8 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bn 50726
Article | Year |
---|---|
Involvement of platelet-activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits.
Topics: Animals; Arthritis; Arthritis, Experimental; Azepines; Dinoprostone; Drug Synergism; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thienopyridines; Tumor Necrosis Factor-alpha | 1992 |
Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits.
Topics: Animals; Arrhythmias, Cardiac; Azepines; Blood Pressure; Electrocardiography; Heart Rate; Hemodynamics; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Platelet Activating Factor; Rabbits; Thienopyridines; Triazoles | 1992 |
Prolonged effect of a new platelet-activating factor antagonist on ocular vascular permeability in an endotoxin model of uveitis.
Topics: Animals; Azepines; Capillary Permeability; Cornea; Dextrans; Endotoxins; Eye; Fluoresceins; Injections; Keratitis; Platelet Activating Factor; Rabbits; Thienopyridines; Uveitis | 1991 |
Recovery of postischemic brain metabolism and function following treatment with a free radical scavenger and platelet-activating factor antagonists.
Topics: Adenosine Monophosphate; Animals; Azepines; Brain; Creatine; Dimethyl Sulfoxide; Dogs; Electroencephalography; Evoked Potentials, Auditory; Free Radical Scavengers; Glucose; Glycogen; Hydrogen-Ion Concentration; Ischemic Attack, Transient; Kinetics; Oxygen; Phosphocreatine; Platelet Activating Factor; Thienopyridines; Triazoles; Vascular Resistance | 1991 |
Platelet-activating factor potentiates interleukin-1/epidermal cell-derived thymocyte-activating factor release by guinea-pig keratinocytes stimulated with lipopolysaccharide.
Topics: Animals; Azepines; Diterpenes; Drug Synergism; Ginkgolides; Guinea Pigs; In Vitro Techniques; Interleukin-1; Keratinocytes; Lactones; Lipopolysaccharides; Platelet Activating Factor; Thienopyridines | 1990 |
LDL induced shape change reaction of platelets is not due to PAF.
Topics: Azepines; Blood Platelets; Glyceryl Ethers; Humans; In Vitro Techniques; Lipoproteins, LDL; Platelet Activating Factor; Thiazoles; Thienopyridines; Triazolam | 1989 |
An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats.
Topics: Animals; Azepines; Diterpenes; Encephalomyelitis, Autoimmune, Experimental; Female; Ginkgolides; Lactones; Platelet Activating Factor; Rats; Thienopyridines; Time Factors | 1989 |
Protection against cyclosporin-induced nephrotoxicity: 1. Effect of a PAF antagonist, BN50726.
Topics: Animals; Azepines; Creatinine; Cyclosporine; Drug Interactions; Glutathione; Kidney Cortex; Kidney Diseases; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Thienopyridines; Urea | 1994 |